News

On Friday, a federal judge permanently blocked the National Institutes of Health from implementing indirect cost caps on ...
The Trump administration’s effort to slash federal funding to universities has found its latest targets, with the government ...
Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating ...
With two attempts to merge with other companies having collapsed, Vincerx Pharma has been left with no choice but to ...
Caris Life Sciences has collected $168 million in new funding to support the growth of its precision medicine platforms, ...
AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...
Researchers combined a vaccine and a probiotic supplement to tend the microbial garden inside the intestines of mice, ...
Oncology health tech firm Flatiron Health will use Massive Bio’s patient database to identify and recruit participants for clinical trials, the Roche Group affiliate announced in an April 7 release.
Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...
The Trump administration has blocked access to multiple data repositories maintained by the National Institutes of Health ...
GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...
Global CRO Worldwide Clinical Trials has enlisted AI tech firm NetraMark to discover patient subpopulations hidden inside ...